-
manufactured and sold in the
United States by
Celgene under the
trade name
Abraxane where it is
designated as an
orphan drug as first-line treatment, in combination...
-
medical researcher, and
transplant surgeon. He is the
inventor of the drug
Abraxane,
which is used for lung, breast, and
pancreatic cancer. Soon-Shiong is...
-
approved protein-bound pa****axel (also
known as nab-pa****axel, sold as
Abraxane) used with gemcitabine. This
regimen may be less toxic—but
perhaps less...
- and non-small-cell lung cancers. Albumin-bound pa****axel (brand name
Abraxane, also
called nab-pa****axel) is an
alternative formulation where pa****axel...
-
chemotherapeutic compound,
called nab Technology. From this the
company developed Abraxane, a
treatment for
metastatic breast cancer. In 2010,
Abraxis BioScience...
-
Doxorubicin Epirubicin Idarubicin Mitoxantrone Pirarubicin Valrubicin Zorubicin Abraxane Cabazitaxel Docetaxel Larotaxel Pa****axel
Taxotere Tesetaxel Ixabepilone...
- and
transplant surgeon Patrick Soon-Shiong is the
inventor of the drug
Abraxane,
which became known for its
efficacy against lung, breast, and pancreatic...
- progression-free survival.
Taxanes are very
active in
metastatic breast cancer, and
abraxane is
approved for
patients with
metastatic breast cancer who
either relapsed...
- in its
expansion into
drugs that
attack solid tumors.
Abraxis produced Abraxane, the cancer-fighting drug that can be
given in high doses. In November...
-
acquired Celgene's
operations in
China as well as the
rights to
commercialize Abraxane,
Revlimid and Vidaza, Celgene's
approved drugs in China. As part of the...
